Related references
Note: Only part of the references are listed.Inhibitors of Deacetylases Suppress Oncogenic KIT Signaling, Acetylate HSP90, and Induce Apoptosis in Gastrointestinal Stromal Tumors
Thomas Muehlenberg et al.
CANCER RESEARCH (2009)
RIP Kinases at the Crossroads of Cell Death and Survival
Wim Declercq et al.
CELL (2009)
Mcl-1 is a potential therapeutic target in multiple types of cancer
C. Akgul
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
CK2: The kinase controlling the Hsp90 chaperone machinery
Y. Miyata
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
CK2: A key player in cancer biology
J. H. Trembley et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors
J. R. Smith et al.
ONCOGENE (2009)
Histone deacetylase inhibitor SAHA induces ERα degradation in breast cancer MCF-7 cells by CHIP-mediated ubiquitin pathway and inhibits survival signaling
Xin Yi et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer
Sang Hyub Lee et al.
CANCER LETTERS (2008)
Protein kinase CK2 in human diseases
Barbara Guerra et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Targeting the oncogene and kinome chaperone CDC37
Phillip J. Gray et al.
NATURE REVIEWS CANCER (2008)
Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells
Phillip J. Gray et al.
CANCER RESEARCH (2007)
Apigenin-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human prostate cancer cells
Sanjeev Shukla et al.
CELL CYCLE (2007)
Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells
Kashif A. Ahmad et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Protein kinase CK2α as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia
Jin Seok Kim et al.
CLINICAL CANCER RESEARCH (2007)
Cdc37 has distinct roles in protein kinase quality control that protect nascent chains from degradation and promote posttranslational maturation
Atin K. Mandal et al.
JOURNAL OF CELL BIOLOGY (2007)
RIP1, a kinase on the crossroads of a cell's decision to live or die
N. Festjens et al.
CELL DEATH AND DIFFERENTIATION (2007)
Multiple myeloma cell survival relies on high activity of protein kinase CK2
Francesco A. Piazza et al.
BLOOD (2006)
Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents
Julie A. Vrana et al.
APOPTOSIS (2006)
Inhibition of interleukin-4 production in activated T cells via down-regulation of NF-AT DNA binding activity by apigenin, a flavonoid present in dietary plants
J Park et al.
IMMUNOLOGY LETTERS (2006)
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival
S Wuillème-Toumi et al.
LEUKEMIA (2005)
Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways
J Fang et al.
FASEB JOURNAL (2005)
Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells
TD Way et al.
FEBS LETTERS (2005)
MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol
AM Domina et al.
ONCOGENE (2004)
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis
S Le Gouill et al.
BLOOD (2004)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Suppression of constitutive and tumor necrosis factor α-induced nuclear factor (NF)-κB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells:: Correlation with down-regulation of NF-κB-responsive genes
S Shukla et al.
CLINICAL CANCER RESEARCH (2004)
CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37
Y Miyata et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Phosphorylation of serine 13 is required for the proper function of the Hsp90 co-chaperone, Cdc37
JY Shao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A positive feedback loop between protein kinase CKII and Cdc37 promotes the activity of multiple protein kinases
S Bandhakavi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
DW Litchfield
BIOCHEMICAL JOURNAL (2003)
The BCL2 family: Regulators of the cellular life-or-death switch
S Cory et al.
NATURE REVIEWS CANCER (2002)
Antisense strategy shows that Mcl-1 rather than Bcl-2 or BCI-xL is an essential survival protein of human myeloma cells
S Derenne et al.
BLOOD (2002)
Myeloid cell factor-1 is a critical survival factor for multiple myeloma
B Zhang et al.
BLOOD (2002)
Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2')
S Sarno et al.
FEBS LETTERS (2001)
Disruption of Hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation
J Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
